Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Wilson's Disease

What is Wilson's Disease?

Wilson’s Disease is a rare genetic disorder characterized by the accumulation of excess copper in various organs, particularly the liver, brain and eyes. This condition leads to liver-related symptoms such as hepatitis, hepatomegaly, jaundice, and cirrhosis, as well as neurological symptoms including tremors, poor coordination, speech difficulties, and movement disorders. Psychiatric symptoms like depression, anxiety, mood swings, and psychosis are also common. Serious risks include liver failure, progressive neurological impairment, hepatocellular carcinoma, and hemolytic anemia. The condition is progressive and can lead to severe health complications if untreated. Early diagnosis and lifelong management, involving medications to remove excess copper and regular monitoring, are essential to prevent severe complications.

 

Wilson’s Disease is a rare genetic disorder characterized by the accumulation of excess copper in various organs, particularly the liver, brain and eyes. This condition leads to liver-related symptoms such as hepatitis, hepatomegaly, jaundice, and cirrhosis, as well as neurological symptoms including tremors, poor coordination, speech difficulties, and movement disorders. Psychiatric symptoms like depression, anxiety, mood swings, and psychosis are also common. Serious risks include liver failure, progressive neurological impairment, hepatocellular carcinoma, and hemolytic anemia. The condition is progressive and can lead to severe health complications if untreated. Early diagnosis and lifelong management, involving medications to remove excess copper and regular monitoring, are essential to prevent severe complications.

Acknowledgement of Wilson's Disease has not been added yet.

Wilson’s Disease has an estimated prevalence of 1 in 30,000 worldwide, affecting those born male and female equally. It is typically diagnosed between 5 and 35 years of age, although it can appear at any age.

Name Abbreviation
Hepatolenticular degeneration, Wilson's hepatolenticular degeneration, Progressive lenticular degeneration

Wilson’s Disease is caused by mutations in the ATP7B gene which regulates copper metabolism. The protein derived from this gene is responsible for transporting copper from the liver to other parts of the body, incorporating copper into certain enzymes, and plays a role in removing excess copper from the body and excreting it into bile, which is then eliminated through the digestive tract. Mutations in the ATP7B gene lead to a malfunction of this copper-transporting protein. Copper accumulates in the liver, and over time, is released into the bloodstream and deposited in organs such as the brain, kidneys and eyes, causing the symptoms associated with the disease.


Wilson’s Disease is inherited in an autosomal recessive pattern (see RareShare Guide on Genetic Inheritance). Individuals must inherit two copies of the mutated gene, one from each parent, in order to express the trait of Wilson’s Disease. The parents having one mutated gene do not show symptoms of the disease.

Wilson’s Disease symptoms can vary depending on the organs affected and may include the following:

  • Liver Problems:

    • Jaundice (yellowing of the skin and eyes)

    • Hepatitis (inflammation of the liver)

    • Cirrhosis (scarring or damage to the liver)

    • Abdominal swelling

    • Easy bruising and bleeding

  • Neurological Symptoms:

    • Tremors

    • Muscle stiffness

    • Difficulty with speech and swallowing

    • Poor coordination

    • Unsteady gait

  • Psychiatric Symptoms:

    • Depression

    • Anxiety

    • Mood swings

    • Behavioral changes

    • Sleep disturbances

  • Ocular Symptoms:

    • Kayser-Fleischer rings (golden-brown rings around the irises of the eyes)

  • Other Symptoms:

    • Fatigue

    • Joint pain

    • Anemia

    • Kidney problems

    • Abnormal blood vessels in the esophagus (esophageal varices)

Diagnosis of Wilson’s Disease may include the following:

  • Blood tests:  Measurements to detect elevated serum copper levels and liver enzymes, low levels of ceruloplasmin (a copper-carrying protein).

  • Urine test:  Measure amount of copper excreted in 24 hours.

  • Liver biopsy:  Measure amount of copper in liver tissue.

  • Eye examination:  Look for Kayser-Fleischer ring deposits in the cornea by slit-lamp examination

Genetic testing:  Identify ATP7B gene mutations

Diagnostic tests of Wilson's Disease has not been added yet

Treatment for Wilson’s Disease aims to reduce copper levels in the body and prevent further accumulation. This may include the following options:

  • Chelation therapy:  Use of medications such as d-penicillamine or trientine to bind copper and facilitate its excretion in urine.

  • Zinc acetate:  Blocks the absorption of copper from the diet in the intestine.

  • Dietary changes:  Avoidance of foods high in copper such as shellfish, liver, nuts, chocolate and mushrooms.

  • Liver transplantation:  In cases with severe liver damage or failure, a liver transplant may be needed.

With early diagnosis and appropriate treatment, Wilson’s Disease patients can lead normal, healthy lives. Lifelong monitoring and adherence to treatment regimens are essential for disease management. Untreated, the disease can be fatal due to liver failure or severe neurological damage.

Tips or Suggestions of Wilson's Disease has not been added yet.
  1. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008 Jun;47(6):2089-111:  Diagnosis and Treatment of Wilson Disease:  An Update.

  2. American Association for the Study of Liver Diseases:  Practice Guidelines for Diagnosis and Treatment of Wilson Disease.

  3. NORD:  Wilson Disease.

Logo

Wilson's Disease community discussions will be posted here.

There are no new discussions. Start one now!!

Community External News Link
Title Date Link
Pfizer Steps Further In The Door For Gene Therapies 03/25/2019
Medicine by machine: Is A.I. the cure for the world’s ailing drug industry? 02/09/2020
AstraZeneca drug for rare disease shows promise in flushing copper build-up 08/29/2021
General Hospital' star Bergen Williams dead at 62 after battling rare Wilson's disease 11/20/2021
RARE's Wilson Disease Candidate Betters Standard Therapy in Study 10/04/2024
Community Resources
Title Description Date Link
Volunteers wanted for Wilson Disease study

Wilson disease, also known as copper storage disease or hepatolenticular degeneration syndrome, is a rare disorder that can cause copper to accumulate in the liver, brain, and other vital organs. Researchers at Ultragenyx are conducting studies to better understand Wilson disease, and will use these findings to help move the science forward.

Do you have a Wilson disease diagnosis? Wilson disease research is progressing, but can’t move forward without volunteers. Answer a few questions to see if you may be eligible to take part in research studies sponsored by Ultragenyx.

New Wilson disease research can’t move forward without volunteers like you.

06/04/2021

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

I'm a 23 year old jewish Ashkenazi female with a presumptive diagnosis of the neurological manifestation of Wilson's Disease. I suffer from a number of addiction,...


Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum

Logo

Wilson's Disease community discussions will be posted here.

There are no new discussions. Start one now!!


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.